ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Evaluation of a Change in Pharmacy Discharge Medication Education for Kidney Transplant Recipients

    M. Borsh1, M. Leick1, A. Donovan2, C. McAdam-Marx2, M. Keck1

    1Pharmacy, Nebraska Medicine, Omaha, NE, 2College of Pharmacy, University of Nebraska Medical Center, Omaha, NE

    *Purpose: To evaluate if modification of pharmacy discharge education for kidney transplant recipients contributed to a decreased length of hospital stay (LOS) post-transplant.*Methods: This was…
  • 2022 American Transplant Congress

    Impact of COVID on Transplant Professionalism

    A. Luxon1, D. Brennan2, F. Latif3, M. Flattery4, S. Aryal5

    1CareDx, South San Francisco, CA, 2Johns Hopkins Medical Institute, Baltimore, MD, 3Columbia University, New York, NY, 4Virginia Commonwealth University, Richmond, VA, 5Inova Fairfax Hospital, Falls Church, VA

    *Purpose: Although, much has been written about COVID risk and immunization efficacy in transplant recipients, there is little data on the impact of COVID on…
  • 2022 American Transplant Congress

    Liver Transplant Recipient Gender and Race: Impact on Clinical Outcomes

    M. M. French1, R. Mangus1, R. Holmes1, A. Krause1, J. Sumner1, C. Kubal2, B. Ekser3, P. Mihaylov4, J. Fridell5, A. Lutz6

    1Department of Surgery, Indiana University, Indianapolis, IN, 2Department of Surgery, Indiana University Hospital, Indianapolis, IN, 3Surgery, Indiana University - Transplant Surgery, Indianapolis, IN, 4Department of Surgery, Indiana Univ School of Medicine, Indianapolis, IN, 5Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, 6Indiana University, Fishers, IN

    *Purpose: Background. Health disparities are present in transplantation. This is a retrospective review of liver transplant (LT) recipients determining the impact of race/gender on early…
  • 2022 American Transplant Congress

    Direct Comparison of Clinical Outcomes with Belatacept-Based Regimens to Calcineurin Inhibitors Among DCD and/or High KDPI Kidney Transplant Recipients

    A. Rizvi1, M. Kueht2, S. Hussain3, J. Fair2, R. Ramirez4, A. Gamilla-Crudo5, M. Mujtaba5

    1Internal Medicine, Nephrology, University of Texas Medical Branch at Galveston, Galveston, TX, 2Surgery, University of Texas Medical Branch, Galveston, TX, 3University of Texas Medical Branch, Houston, TX, 4Surgery, University of Texas Medical Branch at Galveston, Galveston, TX, 5University of Texas Medical Branch, Galveston, TX

    *Purpose: Belatacept, an inhibitor of the T-cell costimulatory pathway, can be used in recipients of Donation after Cardiac Death (DCD) and high Kidney Donor Profile…
  • 2022 American Transplant Congress

    Antibody Responses to an Additional Dose of SARS-CoV-2 mRNA Vaccine in Solid Organ Transplant Recipients with and without HIV

    M. Saksena1, G. Carrara2, B. Haydel2, A. Azad1, K. Srivastava1, C. Gleason1, K. Beach1, L. Sominsky1, A. Oostenink1, G. Cai1, J. Carreno Quiroz1, G. Singh1, S. Florman2, C. Cordon-Cardo3, J. Aberg4, A. Wajnberg5, F. Krammer1, V. Simon1, M. Rana4

    1Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 2Recanati/Miller Transplantation Institute, Mount Sinai Hospital, New York, NY, 3Pathology, Molecular and Cell based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 4Infectious Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 5General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY

    *Purpose: Solid organ transplant (SOT) recipients mount suboptimal immune responses to a two-dose SARS-CoV-2 mRNA vaccine series. Data regarding antibody responses in HIV and SOT…
  • 2022 American Transplant Congress

    Donor Black Race Modifies the Association Between Increasing Donor Age and Graft Failure Following Living Kidney Transplantation

    K. Atiemo, R. Baudier, A. Anderson

    Tulane University, New Orleans, LA

    *Purpose: Transplantation utilizing Black living donor kidneys is associated with poorer outcomes.A possible explanation is genetic(APOL1). Kidneys from healthy older Black donors are considered lower…
  • 2022 American Transplant Congress

    Kinetics of dd-cfDNA in Kidney Transplant Recipients Following Sars-CoV-2 Vaccination Booster Administration

    N. M. Ali1, S. Mehta1, V. Tatapudi1, A. Mattoo1, I. Soomro1, J. Benstein1, H. Neumann1, F. Zervou1, J. Miles2, R. Montgomery1

    1Transplant Institute, NYU Langone Health, New York, NY, 2CareDx, Brisbane, CA

    *Purpose: Evolving data suggests booster vaccine doses enhance the immunogenicity of SARS-CoV-2 vaccines in solid organ transplant recipients with higher IgG responses, neutralizing antibodies titers,…
  • 2022 American Transplant Congress

    Identification Of A Novel Peripheral Blood Six-gene Signature Diagnosing Subclinical Acute Rejection After Renal Transplantation

    H. Zhang, Y. Xu, Y. Wang, X. Hu

    Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China

    *Purpose: Given the insensitivity and nonspecificity of serum creatinine, invasive surveillance biopsies are the main way to detect subclinical acute rejection (subAR) in the absence…
  • 2022 American Transplant Congress

    Results Of The Ctot19 Trial: Infliximab (IFX) Induction Does Not Impact 2-year Outcomes In Deceased Donor Kidney Transplant Recipients

    P. Heeger1, B. Armstrong2, T. Alhamad3, D. Brennan4, J. Bromberg5, S. Bunnapradist6, S. Chandran7, R. Fairchild8, D. Foley9, R. Formica10, I. W. Gibson11, D. Hricik12, K. Kesler2, R. B. Mannon13, M. Menon10, K. Newell14, P. Nickerson11, J. Odim15, E. Poggio8, R. Sung16, R. Shapiro1, K. Tinckam17, F. Vincenti7

    1Mount Sinai, New York, NY, 2Rho, Durham, NC, 3Washington U, Saint Louis, MO, 4Johns Hopkins, Baltimore, MD, 5U Maryland, Baltimore, MD, 6UCLA, Los Angeles, CA, 7UCSF, San Francisco, CA, 8Cleveland Clinic, Cleveland, OH, 9U Wisconsin, Madison, WI, 10Yale, New Haven, CT, 11U Manitoba, Winnipeg, MB, Canada, 12U Hosp Case, Cleveland, OH, 13U Nebraska, Omaha, NE, 14Emory, Atlanta, GA, 15NIAID NIH, Rockville, MD, 16U Michigan, Ann Arbor, MI, 17U Hlth Network, Toronto, ON, Canada

    *Purpose: Ischemia-reperfusion (IR) of a kidney transplant (KTx) up-regulates tumor necrosis factor alpha (TNF) production within the allograft. IR-induced TNF amplifies post-KTx allograft inflammation and…
  • 2022 American Transplant Congress

    CD8+ T Cells Differentiate into a CD43-expressing Effector Population After Transplantation

    G. Cohen, M. A. Kallarakal, S. M. Krummey

    Department of Pathology, Johns Hopkins University, Baltimore, MD

    *Purpose: Despite a significantly reduced toxicity profile and improved long-term graft function versus calcineurin inhibitors, widespread adaptation of belatacept (CTLA-4 Ig) has been limited due…
  • « Previous Page
  • 1
  • …
  • 162
  • 163
  • 164
  • 165
  • 166
  • …
  • 190
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences